Journal of Multiple Sclerosis

Ups and Downs in MS Therapeutics

Abdul Aftab and Pankaj Majlumdar*

DOI: 10.35248/2376-0389.24.11.1.535

Unlocking the Pivotal Role of Ocrelizumab in Transforming Multiple Sclerosis Treatment

Martin Baum* and Richard Glenn

DOI: 10.35248/2376-0389.24.11.1.539.

Unveiling the Burden: Rates and Predictors of Short-Term Disability Claims among Migraine Patients in the US

David Reeds* and Sarah Frowler

DOI: 10.35248/2376- 0389.23.11(1).538

Unlocking the Long-Term Value Proposition: A Comprehensive Analysis of the Cost-Effectiveness of Glatiramer Acetate in the Treatment Landscape of Relapsing-Remitting Multiple Sclerosis from the UK NHS Perspective

Elche Greeds* and Oman Godsy

A Comprehensive Review of the Long-Term Effectiveness and Safety of Ocrelizumab as a Disease-Modifying Therapy for Multiple Sclerosis

Johnny Michael Sakr*